Trade Madrigal Pharmaceuticals, Inc. (Extended hours) - MDGL CFD
Add to favourite- Summary
- Historical Data
| Spread | 4.65 | ||||||||
|
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023429% | ||||||||
|
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001207% | ||||||||
| Overnight fee time | 21:00 (UTC) | ||||||||
| Min traded quantity | 0.1 | ||||||||
| Currency | USD | ||||||||
| Margin | 50.00% | ||||||||
| Stock exchange | United States of America | ||||||||
| Commission on trade | 0% |
| Prev. Close | 291.88 |
| Open | 298.74 |
| 1-Year Change | 41.34% |
| Day's Range | 294.66 - 307.16 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
| Date | Close | Change | Change (%) | Open | High | Low |
|---|---|---|---|---|---|---|
| Apr 21, 2025 | 291.88 | -8.55 | -2.85% | 300.43 | 300.43 | 275.98 |
| Apr 17, 2025 | 298.95 | -5.00 | -1.65% | 303.95 | 309.04 | 298.17 |
| Apr 16, 2025 | 306.22 | -12.22 | -3.84% | 318.44 | 320.73 | 295.45 |
| Apr 15, 2025 | 321.05 | -1.29 | -0.40% | 322.34 | 328.03 | 314.53 |
| Apr 14, 2025 | 319.57 | -14.86 | -4.44% | 334.43 | 334.43 | 313.93 |
| Apr 11, 2025 | 313.16 | 0.22 | 0.07% | 312.94 | 321.80 | 303.07 |
| Apr 10, 2025 | 303.57 | -7.86 | -2.52% | 311.43 | 312.41 | 292.95 |
| Apr 9, 2025 | 310.90 | 5.86 | 1.92% | 305.04 | 329.74 | 289.50 |
| Apr 8, 2025 | 299.95 | -21.00 | -6.54% | 320.95 | 325.46 | 299.95 |
| Apr 7, 2025 | 308.90 | 2.75 | 0.90% | 306.15 | 320.16 | 290.45 |
| Apr 4, 2025 | 313.43 | -11.01 | -3.39% | 324.44 | 324.44 | 308.95 |
| Apr 3, 2025 | 324.95 | 2.74 | 0.85% | 322.21 | 334.18 | 320.40 |
| Apr 2, 2025 | 335.94 | 20.98 | 6.66% | 314.96 | 340.97 | 314.96 |
| Apr 1, 2025 | 319.95 | -8.50 | -2.59% | 328.45 | 334.56 | 319.95 |
| Mar 31, 2025 | 330.51 | 10.56 | 3.30% | 319.95 | 332.27 | 307.17 |
| Mar 28, 2025 | 322.71 | -8.27 | -2.50% | 330.98 | 335.21 | 322.71 |
| Mar 27, 2025 | 334.92 | 4.96 | 1.50% | 329.96 | 337.49 | 329.96 |
| Mar 26, 2025 | 329.95 | -9.75 | -2.87% | 339.70 | 342.45 | 329.95 |
| Mar 25, 2025 | 341.33 | -3.10 | -0.90% | 344.43 | 350.65 | 334.95 |
| Mar 24, 2025 | 338.45 | -7.49 | -2.17% | 345.94 | 347.25 | 337.95 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 20
- 100
- 500
- 1000
- 10000
Madrigal Pharmaceuticals, Inc. Company profile
About Madrigal Pharmaceuticals Inc
Madrigal Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. The Company’s lead product candidate, MGL-3196 (resmetirom), is a liver-directed, selective thyroid hormone receptor-ß (THR-ß) agonist for the treatment of non-alcoholic steatohepatitis (NASH)and heterozygous familial hypercholesterolemia (HeFH). Its product pipeline also includes MGL-3745, which is used in the treatment of NASH and HeFH.
Financial summary
BRIEF: For the fiscal year ended 31 December 2021, Madrigal Pharmaceuticals Inc revenues was not reported. Net loss increased 20% to $241.8M. Higher net loss reflects R & D increase of 11% to $194.5M (expense), G & A increase from $10M to $21.1M (expense), Stock-based Compensation in SGA increase of 36% to $16.2M (expense). Basic Earnings per Share excluding Extraordinary Items decreased from -$13.09 to -$14.63.
Equity composition
Common Stock $.0001 Par, 10/10, 100M auth., 42,166,779 issd. Insiders control approx. 37.8%. IPO: 2/06/07, 5M shares @ $10 per share by Bear, Stearns & Co. Inc.
| Industry: | Bio Therapeutic Drugs |
200 Barr Harbor Dr Ste 400
WEST CONSHOHOCKEN
PENNSYLVANIA 19428-2978
US
News
ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com